[1]
Magnani, H.N. et al. 2026. Danaparoid Sodium (Orgaran®): An Update on its Approved Indications. Journal of Cardiology and Cardiovascular Medicine. (Aug. 2026), 33–57. DOI:https://doi.org/10.29328/journal.jccm.1001228.